Progenics Pharmaceuticals Inc Revenue per Employee (PGNX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Progenics Pharmaceuticals Inc  (PGNX)
 

Progenics Pharmaceuticals Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 45.95% in the first quarter 2020, year on year to cumulative value of $37 million, Progenics Pharmaceuticals Inc's revenue per employee grew on a trailing twelve months basis to $ 369,530. The productivity of Progenics Pharmaceuticals Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 99 other companies have achieved higher revenue per employee. While Progenics Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 0 to 1433. Progenics Pharmaceuticals Inc has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PGNX Revenue per Employee (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Revenue Change 45.95 % 367.14 % 5.57 % 156.99 % 34.24 %
Sales per Employee (TTM) $ 369,530 349,860 230,980 228,020 167,140
PGNX's Total Ranking # 1433 # 0 # 0 # 0 # 0
Seq. Revenue Change -58.69 % 169.48 % -43.68 % 132.8 % 32.21 %

PGNX Company Profile >> Back to PGNX Efficiency Comparisons >> Compare PGNX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 61
Healthcare Sector # 100
Overall Market # 1433

Revenue per Employee Statistics
High Average Low
$ 694,290 $ 282,015 $ 71,270
(Dec 31 2016)   (June 30. 2014)



Financial Statements
Progenics Pharmaceuticals Inc's Revenue MRQ $ 6 Millions Visit PGNX's Income Statement
Progenics Pharmaceuticals Inc's Revenues TTM $ 37 Millions Visit PGNX's aggregate revenue growth
What are PGNX's Sales? Visit PGNX's Sales by Segment




Other Ratios
Progenics Pharmaceuticals Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PGNX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PGNX's Competitors
Revenue per Employee for PGNX's Suppliers
Revenue per Employee for PGNX's Customers

You may also want to know
PGNX's Sales Growth Rates PGNX's Pe Price to earnings ratio PGNX's Receivables Turnover Ratio PGNX's Stock Quote
PGNX's Net Income Growth Rates PGNX's Ps Price to Sales ratio PGNX's Sales per Employee PGNX's Asset Turnover Ratio
PGNX's Net Margin PGNX's Pb Price to Book ratio PGNX's Financial Strength Ratios PGNX's Dividend Payout Ratio
Date modified: 2026-09-08T15:09:55+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2020, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2020Number of Employees Mar 31 2020
Takeda Pharmaceutical Company Limited  644,215.22 $ 30,278.115  Million 47,000 
Merck and Co Inc   641,080.00 $ 48,081.000  Million 75,000 
Perrigo Company Plc  617,765.43 $ 5,003.900  Million 8,100 
Supernus Pharmaceuticals inc   616,958.59 $ 402.257  Million 652 
Abbvie Inc   597,491.23 $ 34,057.000  Million 57,000 
Rigel Pharmaceuticals Inc  588,649.43 $ 102.425  Million 174 
Johnson and Johnson  587,563.92 $ 82,729.000  Million 140,800 
Alkermes Plc   582,470.73 $ 1,194.065  Million 2,050 
Biomarin Pharmaceutical Inc  560,500.47 $ 1,805.372  Million 3,221 
Fortress Biotech Inc   552,179.49 $ 43.070  Million 78 
Milestone Scientific Inc   551,331.87 $ 8.270  Million 15 
Smiledirectclub Inc   549,530.71 $ 769.343  Million 1,400 
Enovis Corp  539,173.67 $ 4,206.633  Million 7,802 
Seres Therapeutics Inc   535,954.55 $ 35.373  Million 66 
Pediatrix Medical Group Inc   535,206.25 $ 3,508.277  Million 6,555 
3m Company  534,677.69 $ 32,348.000  Million 60,500 
Morphic Holding inc   532,322.58 $ 16.502  Million 31 
Pacira Biosciences inc   525,207.48 $ 435.397  Million 829 
Cardiovascular Systems Inc   524,466.00 $ 262.233  Million 500 
Regeneron Pharmaceuticals Inc   517,832.58 $ 7,979.800  Million 15,410 
Logicmark Inc  506,049.09 $ 16.700  Million 33 
Accuray Incorporated  501,072.93 $ 405.368  Million 809 
Teva Pharmaceutical Industries Limited  499,234.17 $ 16,949.000  Million 33,950 
Prophase Labs Inc   497,157.89 $ 9.446  Million 19 
Kaya Holdings Inc   492,909.50 $ 0.986  Million 2 
Healthlynked Corp  489,076.80 $ 4.891  Million 10 
Sarepta Therapeutics Inc   488,019.16 $ 407.496  Million 835 
Spero Therapeutics Inc   485,200.00 $ 12.130  Million 25 
Adamas Pharmaceuticals Inc  478,775.00 $ 57.453  Million 120 
Hookipa Pharma inc   478,678.57 $ 13.403  Million 28 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.